US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antibody Technologies Market Research Reports & Industry Analysis

RSS Feeds

Antibody Technologies Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Antibodies in Oncology Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... for the second wave in the lucrative field of therapeutic antibodies. There are today 490 companies plus partners developing 1039 antibody drugs in 2692 developmental projects in cancer. In addition, there are 6 suspended drugs ...  |  read more...
USD 6,750
Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025
4/24/2015 | published by: Roots Analysis
... many pharmaceutical companies to improve these treatments as well as discover novel cancer therapies with minimum toxic effects. Targeted cancer therapy is an upcoming area gaining strong foothold in the industry and has already become ...  |  read more...
USD 2,199
Anti-CD19 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD19 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD19 Antibody- ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD274 (PD-L1) Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD28 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD28 Antibody- ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD3 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD3 Antibody- ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD30 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD30 Antibody- ...  |  read more...
USD 1,250
Anti-CD37 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD37 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD37 Antibody- ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD4 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD4 Antibody- ...  |  read more...
USD 1,250
Anti-CD40 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD40 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD40 Antibody- ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD6 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD6 Antibody- ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD70 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD70 Antibody- ...  |  read more...
USD 1,250
Anti-CS1 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CS1 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CS1 Antibody- ...  |  read more...
USD 1,250
Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-Dickkopf-1 (Dkk-1) Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Aurora A Kinase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Conference Documentation: ADC Summit 2015
5/19/2015 | published by: SMI Publishing, Ltd
... payload of an ADC is critical. This conference goes to the heart of the technological challenges and asks: What does it take to develop superior ADCs and gain the clinical edge? Join us as we ...  |  read more...
USD 788.78
The 2016 Report on AntiCD20 Monoclonal Antibodies: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by ...  |  read more...
USD 995
Global Immunoglobulin M Detection Kit Industry 2015 Market Research Report
5/18/2015 | published by: 9Dimen Research
... (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Immunoglobulin M Detection Kit basics: definitions, classifications, applications and industry chain overview; industry policies and ...  |  read more...
USD 2,850
Next-Generation Antibody Therapies Market Forecast 2015-2025
5/15/2015 | published by: Visiongain
... revenues to 2025, assessing data, trends, opportunities and prospects there. Our 236-page report provides 126 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study ...  |  read more...
USD 2,788
The 2016-2021 World Outlook for AntiCD20 Monoclonal Antibodies
4/6/2015 | published by: Icon Group International, Inc.
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader ...  |  read more...
USD 995
Global Immunodiagnostics Market 2015-2019
4/29/2015 | published by: TechNavio - Infiniti Research Ltd.
... analytical methods that require different immunodiagnostics instruments and antibodies as reagents against the desired antigens to be detected. The results of the tests are used to help in diagnosis, and they have widespread clinical applications. ...  |  read more...
USD 2,500
Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019
5/1/2015 | published by: MarketsandMarkets
... market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have led to the development of hybridoma-free technologies ...  |  read more...
USD 4,650
Anti-CD22 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD22 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD22 Antibody- ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD25 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD25 Antibody- ...  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD279 (PD-1) Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10